St Jude Medical has announced that it will immediately deploy the latest release of cyber security updates for its Merlin remote monitoring system, used with implantable pacemakers and defibrillator devices.
Alvimedica has received the CE mark for its new polymer-free amphilimus-eluting stent, Cre8 EVO. Cre8 EVO is designed to provide a controlled elution of the amphilimus formulation (a combination of sirolimus and fatty acid) through its abluminal reservoir technology.
MicroPort Medical has recently completed the patient enrolment of the pre-market clinical trial of its self-developed VitaFlow transcatheter aortic valve and delivery system (VitaFlow), which is three months prior to the scheduled completion date.
Somahlution has announced enrolment of the first patient in its DuraGraft coronary artery bypass grafting (CABG) European Registry. The registry will evaluate DuraGraft—a vascular graft treatment that, according to a press release, significantly improves long-term clinical outcomes following CABG. The registry will include 3,000 patients from 50 plus European sites across 10 countries. The first enrolled patient was treated at Galway University Hospital, Galway, Ireland.
A new study indicates that “transcatheter valve-in ring”—implanting a transcatheter valve in a surgically placed annuloplasty ring—may be a clinically effective approach for managing tricuspid regurgitation in previously treated patients. However, investigators Jamil Aboulhosn (David Geffen School of Medicine at UCLA, Division of Cardiology, UCLA, Los Angeles, USA) and others found that paravalvular leak was common after the procedure and may lead to further interventions.
NaviGate Cardiac Structures has announced that a novel valved stent that can capture the enlarged annulus in patients with functional tricuspid regurgitation was successfully implanted in a patient with massive incompetence of the tricuspid valve. The company reports that after the implantation, the valve demonstrated excellent valvular function, indicating correction of the massive regurgitation problem.
Twelve-month clinical results from Medinol’s BIONICS study have demonstrated that the company’s Elunir stent has a good safety profile, among other positive results.
The American College of Cardiology (ACC), along with several partnering organisations, has released updated appropriate use criteria for performing coronary revascularisation in patients with acute coronary syndromes. The criteria have been published by the Journal of the American College of Cardiology.
Women with significant aortic valve disease who undergo transcatheter aortic valve implantation (TAVI) have been traditionally considered at a higher risk than men in certain respects. However, their survival rate one year after having had the procedure is higher than men, according to a study published in the Journal of the American College of Cardiology.
A new report from the American College of Cardiology and the American Heart Association presents 10 quality and performance measures that are intended to help stakeholders—including health systems, legislative bodies, and nongovernmental organisations, as well as healthcare practitioners, patients, families and communities—in the effort to prevent sudden cardiac death. The joint report has been published online in the Journal of the American College of Cardiology and Circulation: Cardiovascular Quality and Outcomes.
Micro Interventional Devices has successfully completed the first clinical implantation of its proprietary MIA (minimally invasive annuloplasty) technology for minimally invasive mitral and tricuspid repair.
A high-sensitivity blood test could be used to predict which patients are at risk of a heart attack according to new research funded by the British Heart Foundation (BHF).
The UK’s National Institute for Health and Care Excellence (NICE) has announced its participation in the US Food and Drug Administration (FDA)’s Payer Communication Taskforce. This programme aims to accelerate US patient access to new technologies by gathering evidence of clinical effectiveness in an attempt to encourage US insurers to fund new treatments, post FDA-approval.
Patients with acute coronary syndrome may be at an increased risk for suicide compared to otherwise healthy people, according to new research in the Journal of the American Heart Association.
Boston Scientific Corporation has closed its acquisition of certain manufacturing assets and capabilities of the Neovasc advanced biological tissue business. With the completion of the acquisition, Boston Scientific will integrate certain manufacturing assets and biologic tissue capabilities into its structural heart business for use in the manufacturing of the Lotus valve systems and future heart valve technologies.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos